announces

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 06, 2026 17:33 ET  | Source: Tango Therapeutics Sub, Inc BOSTON, March 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics,…

3 months ago

Revive Environmental Announces CEO Transition

COLUMBUS, Ohio, March 06, 2026 (GLOBE NEWSWIRE) -- Revive Environmental Technology, LLC, the only company in North America offering commercially…

3 months ago

Bybit Announces Departure of Co-CEO Helen Liu as She Embarks on Entrepreneurial Journey

DUBAI, UAE, March 7, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, today announced that Helen…

3 months ago

AIM ImmunoTech Announces Closing of its Rights Offering

OCALA, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or…

3 months ago

Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute

Study is Real-World Evaluation of the Clinical Utility of Sodium Thiosulfate Injection (PEDMARK®) in Reducing the Risk of Ototoxicity in Adolescent…

3 months ago

The Ferrero Group announces new governance and leadership roles, reporting into Giovanni Ferrero, President of Ferrero International S.A.

Alessandro Nervegna will be appointed as new Chief Executive Officer of Ferrero Core, driving growth of the Group's core categories.…

3 months ago

Persevere Therapeutics Launches as a Clinical-Stage Oncology Company with a Novel Phase 1b/2a Agent and Announces First Close of Seed Financing

Chesterbrook, PA, March 03, 2026 (GLOBE NEWSWIRE) -- Persevere Therapeutics, Inc. (“Persevere”), a Delaware-incorporated, clinical-stage oncology biotechnology company, today announced…

3 months ago

Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical…

3 months ago

3iQ Announces Successful Closing of Previously Announced Transaction with Coincheck Group N.V.

TORONTO, March 2, 2026 /PRNewswire/ -- 3iQ Corp. ("3iQ"), a global pioneer in institutional digital asset investment solutions, is pleased…

3 months ago

Halia Therapeutics Announces Presentation at the BIO Investment & Growth Summit

LEHI, Utah, March 2, 2026 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company advancing therapies grounded in human biology, today…

3 months ago